Global Heart Hub and Novartis partner to tackle ASCVD, a global health crisis and world’s #1 killer


You May Also Like

Aileron Therapeutics Reports First Quarter 2018 Financial Results

CAMBRIDGE, Mass., May 09, 2018 (GLOBE NEWSWIRE) -- Aileron Therapeutics (Nasdaq:ALRN), the clinical-stage leader ...

Chembio Diagnostics Reports Second Quarter 2017 Financial Results

MEDFORD, N.Y., Aug. 09, 2017 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq:CEMI), a leader ...